Molecular Basis of Rabies Virus Virulence. II. Identification of a Site on the CVS Glycoprotein Associated with Virulence
SUMMARY Nine anti-G monoclonal antibodies were used to select mutants of the CVS strain of rabies virus resistant to neutralization. Seven mutants were avirulent in adult mice and two others exhibited an attenuated pathogenicity. Both categories were resistant to monoclonal antibodies 194-2 and 248-8. Virulence appears to be associated with a particular configuration of a region of the glycoprotein which is located at the intersection of the epitopes recognized by these two monoclonal antibodies. Our results confirm the role played by the glycoprotein in the neurovirulence of rabies virus.
In an attempt to understand the molecular basis of rabies virulence, we have prepared a collection of avirulent mutants differing if possible from the virulent CVS strain by a single amino acid substitution.
Direct isolation of avirulent mutants was unsuccessful (absence of avirulent mutants among 100 clones tested; A. Flamand & T. J. Wiktor, unpublished data); therefore, the following screening procedure was devised. Glycoprotein (G) mutants of the virus were selected on the basis of resistance to neutralization by an anti-G neutralizing monoclonal antibody; avirulent mutants were then detected by intracerebral (i.c.) inoculation of adult mice (Coulon et al., 1982a) .
Nine neutralizing monoclonal antibodies (Wiktor & Koprowski, 1978; Flamand et al., 1980) were generously provided by T. J. Wiktor (Wistar Institute, Philadelphia, Pa., U.S.A.). Initially, we isolated 39 mutants resistant to four of these monoclonal antibodies. Two of these mutants were avirulent in adult mice, whatever the concentration of the inoculum. These mutants have been designated AvO1 and AvO2 (Coulon et al., 1982a) . The viral protein pattern of mutants AvO1 and AvO2 and wild-type in SDS-polyacrylamide gels showed no difference. The panel of reactivity towards anti-nucleocapsid monoclonal antibodies showed no modification of the antigenic structure of the AvO1 and AvO2 nucleocapsid protein. Both observations seem to indicate that the mutants retained the general characteristics of the CVS strain.
This study was continued with the isolation of 278 mutants resistant to monoclonal antibodies (Table 1) . Mutants were selected as described by from a 5-fluorouracil (5-FU)-mutagenized CVS stock, with the exception of mutants resistant to 220-8 which were selected from a non-mutagenized CVS clone.
The frequency of mutants in the mutagenized population varied from 3.3 × 10 -4 to 2.8 × 10 -3. The fact that the frequency of mutants resistant to 220-8 in the non-mutagenized CVS population was lower (1-4 x 10 -4) suggests that the mutagenesis indeed increased the frequency of this type of mutant in the population. However, direct comparison between the frequency of spontaneous and induced mutants appears dubious: spontaneous mutants are clonaly distributed and the size of the subclones depends on how early the mutational event occurred.
Only three mutants could be found which were considered to be resistant to antibody 231-22; many of the selected clones did not retain the resistant phenotype after multiplication. This could be due to a low affinity of the antibody for the virus.
The virulence of the mutants was tested by i.c. inoculation in groups of five adult mice. The viruses used in this experiment were chosen from mutants whose resistance to the corresponding monoclonal antibody reached at least 80 % (i.e. the titre in the presence of antibody was at least 80% of the titre in the absence of antibody A clone was defined as resistant when its titre measured in the presence of antibody was more than 10~o of the titre determined without antibody. Sets of five adult Swiss mice were injected i.c. with 1 × 103 to 5 × 103 p.f.u. (in 30 ~tl) of the different mutants. t Origin of the monoclonal antibodies (Flamand et al., 1980) . 719-3 originates from the CVS strain of rabies virus (T. J. Wiktor, personal communication).
Virulence of mutants resistant to neutralization by anti-G monoclonal antibodies*
:~ AvO3 to AvO7. § AvO1 to AvO2. II AtOI to AtO2. * The reactivity of the mutants towards anti-glycoprotein monoclonal antibodies was measured as described by Coulon et al. (1982a) . Briefly, 3 × 102 to 5 x 102 p.f.u, of the virus in 100 I11of minimum essential medium + 0.1% bovine serum albumin were incubated with 10 ~tl of monoclonal antibody for 30 min at room temperature. Survivors were plated on to confluent monolayers of CER cells. Plaques were counted after 5 days incubation at 33 °C. t +, Neutralization; -, no neutralization.
inoculated with 103 of the mutants died within 7 days, as did mice inoculated with the parental strain of CVS (Table 1) . Seven mutants completely lost their virulence in adult mice. Two of them had been selected with antibody 248-8 and five with antibody 194-2. These mutants were designated AvO1 to AvO7 (Av, avirulent; O, Orsay), mutants AvO1 and A'~O2 being the two described previously by Coulon et al. (1982a) . Two other mutants, resistant to antibody 194-2, exhibited attenuated pathogenicity. In the two adult mouse assays, only one out of five animals died in each case, while the others either recovered or showed no symptoms. These mutants were named AtO1 and AtO2 (At, attenuated; O, Orsay). One month later, the surviving mice were injected i.c. with 40 LDso of CVS virus. They all survived the challenge, thus demonstrating the protecting power of the avirulent mutants. Both the avirulent and the attenuated mutants retained their capacity to kill suckling mice. The reactivity of the avirulent and attenuated mutants towards the nine anti-G monoclonal antibodies shows that they were all resistant to 194-2 and 248-8 but neutralized by other antibodies. On the contrary, 18 mutants which were neutralized by only one of these two antibodies retained their virulence (Table 2) .
It has been established that the nine anti-G neutralizing monoclonal antibodies recognize three antigenic sites on the glycoprotein of the CVS strain (Lafon et al., 1983) , following the technique developed by Gerhard et al. (1981) . Our results, compared to the antigenic map of Lafon et al. (1983) , indicate that the site of virulence is located within site no. III, at the intersection of the epitopes recognized by 194-2 and 248-8 antibodies. However, the correlation between resistance to both monoclonal antibodies and the avirulent phenotype is not complete, since one mutant has been isolated which was resistant to 194-2 and 248-8 and which retained its virulence. All the mutants of site no. III were still neutralized by antibodies 509-6, 162-3, 220-8, 231-22, 101-1 and 719-3. This study demonstrates that appropriate anti-G neutralizing monoclonal antibodies allow an efficient selection of avirulent mutants of rabies virus. From 112 mutants which were studied, ten were resistant to both antibodies 194-2 and 248-8, nine of which have lost their virulence. Such mutants were either totally avirulent or their pathogenicity was attenuated. A similar situation has been observed in the HEP strain, a virulent derivative of which became sensitive only to 194-2 and 248-8, while the original avirulent population was resistant to these antibodies (Coulon et al., 1982a) . The fact that attenuated virus strains could be selected with neutralizing monoclonal antibodies has been also illustrated by Spriggs & Fields (1982) with reoviruses.
The avirulent mutants were not functionally affected in vitro; they grew equally well in the BHK-21 or CER hamster cell lines (Smith et al., 1977) and in neuroblastoma cells (NS 20) , nor were they thermosensitive. They seemed to multiply in the nervous system, because they killed Short communications suckling mice when inoculated i.c. as did CVS. The immune response of infected adult mice was different with CVS or AvO1 ; for instance, the production of circulating antibodies was more than 10 times greater in AvOl-infected mice than in CVS-infected mice before their death (Coulon et al., 1982b) and continued to increase for 2 weeks.
Other results, although preliminary, show that the synthesis of cytotoxic cells and interferon was modified in mice inoculated with AvOl or AvO2 (D. Portno'f & M. Kita, personal communication).
We are now attempting to investigate which amino acid substitution(s) is (are) producing the avirulent phenotype. Our avirulent mutants were selected from a 5-FU-mutagenized stock. It is known that this mutagen induces only certain kinds of amino acid substitutions (Drake, 1970) . We are also currently selecting avirulent mutants from non-mutagenized clones of CVS in order to establish a collection of spontaneous independent mutants. The question of whether different amino acid substitutions give rise to the same avirulent phenotype may be answered by comparing the primary structure of the glycoproteins of spontaneous and induced mutants.
The nine neutralizing anti-G monoclonal antibodies allow the study of only part of the glycoprotein structure. It would be interesting to know if modifications in other regions of the glycoprotein may also lead to the loss of virulence.
